Stryker’s Q Guidance System received FDA clearance for cranial applications
pharmafile | February 20, 2023 | News story | Sales and Marketing |
Stryker, a medical technology company, has announced that its Q Guidance System with Cranial Guidance Software received 510(k) clearance from the FDA. Its system for spinal applications is currently on the market.
The Q Guidance system is an image-based planning and intraoperative guidance system. It is indicated for any medical condition where computer-assisted planning and execution would be helpful, and where a reference to a rigid anatomical structure can be identified. The system supports the accurate alignment of the Precision Targeting System with a pre-operatively planned approach; it tracks navigated instruments and displays the position and orientation of the instruments in patient images.
Specifically, the Q Guidance System with Cranial Guidance Software can be used with a range of instruments and accessories for navigated cranial procedures.
Robbie Robinson, president of Stryker’s Spine division, “The FDA clearance of Stryker’s Q Guidance System with Cranial Guidance Software is a key milestone, which will help lead the transformation of cranial navigation and surgery. Our robust pipeline of iterative launches reinforces our commitment to making industry-leading investments focused on providing advanced navigation products and differentiated technologies that our surgeon customers have come to expect.”